[1] 张颖.生殖道感染与HPV感染的关系及引起宫颈癌的危险性分析[J].医学临床研究,2020,37(8):1254-1256. [2] 程正兰,洪艳,贾晓敏. 马鞍山市妇女高危型HPV感染现状分析[J].医学临床研究,2019,36(8):1584-1585. [3] CHEN Q, SHI R, LIU Z, et al. Prognostic significance of negative conversion of high-risk Human Papillomavirus DNA after treatment in Cervical Cancer patients[J].J Cancer,2020, 11(20):5911-5917. [4] COLLINS K, HWANG M, HAMZA A, et al. Prevalence of high-risk human papillomavirus in primary squamous cell carcinoma of urinary bladder[J].Pathol Res Pract,2020, 216(9):153084. [5] AGUAYO F, MUÑOZ JP, PEREZ-DOMINGUEZ F, et al. High-risk human papillomavirus and tobacco smoke interactions in epithelial carcinogenesis[J].Cancers (Basel),2020,12(8):2201. [6] OUH Y T.Risk factors for type-specific persistence of high-risk human papillomavirus and residual/recurrent cervical intraepithelial neoplasia after surgical treatment[J].Obstet Gynecol Sci,2020, 63(5):631-642. [7] KIM Y, JOO Y H, KIM M S, et al. Prevalence of high-risk human papillomavirus and its genotype distribution in head and neck squamous cell carcinomas[J].J Pathol Transl Med,2020, 54(5):411-418. [8] PADHY R R, DAVIDOV A, MADRIGAL L,et al. Detection of high-risk human papillomavirus RNA in urine for cervical cancer screening with HPV 16 & 18/45 genotyping[J].Heliyon,2020, 6(4):e03745. [9] KIM D H, LEE H W, PARK H W, et al. Bee venom inhibits the proliferation and migration of cervical-cancer cells in an HPV E6/E7-dependent manner[J].BMB Rep,2020, 53(8):419-424. [10] DREYER G, MASKE C, STANDER M. Clinical evaluation and budget impact analysis of cervical cancer screening using cobas 4800 HPV screening technology in the public sector of South Africa[J].PLoS One,2019, 14(9):e0221495. [11] CHAO X, SUN T, WANG S, et al. Research of the potential biomarkers in vaginal microbiome for persistent high-risk human papillomavirus infection[J].Ann Transl Med,2020, 8(4):100. |